Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes
出版年份 2013 全文链接
标题
Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 7, Pages 1629-1641
出版商
Wiley
发表日期
2013-11-06
DOI
10.1111/bph.12498
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes
- (2013) D J Baker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus
- (2013) A. Kiyosue et al. DIABETES OBESITY & METABOLISM
- Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin
- (2013) J. P. H. Wilding et al. DIABETES OBESITY & METABOLISM
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo
- (2012) N. Konstantopoulos et al. DIABETES
- Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp
- (2012) M. Sjöstrand et al. DIABETES OBESITY & METABOLISM
- Glucokinase Activators AZD6370 and AZD1656 Do Not Affect the Central Counterregulatory Response to Hypoglycemia in Healthy Males
- (2012) Ensio Norjavaara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms for the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes
- (2012) Elza Muscelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Property based optimisation of glucokinase activators – discovery of the phase IIb clinical candidate AZD1656
- (2012) Michael J. Waring et al. MedChemComm
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
- (2011) J. Shirakawa et al. DIABETES
- Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
- (2011) G. E. Meininger et al. DIABETES CARE
- A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations
- (2011) M. Evans et al. DIABETES OBESITY & METABOLISM
- Pharmacology of Dipeptidyl Peptidase-4 Inhibitors
- (2011) Roberta Baetta et al. DRUGS
- Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice
- (2011) Aurélie Waget et al. ENDOCRINOLOGY
- Sitagliptin: a review
- (2011) Sreevidya Subbarayan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Management of type 2 diabetes: new and future developments in treatment
- (2011) Abd A Tahrani et al. LANCET
- Matrix-based multiparameter optimisation of glucokinase activators: the discovery of AZD1092
- (2011) Michael J. Waring et al. MedChemComm
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
- (2010) R. A. DeFronzo DIABETOLOGIA
- Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1
- (2010) Patricia L. Brubaker ENDOCRINOLOGY
- A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat
- (2010) Sumika Ohyama et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Determination of metformin in mouse, rat, dog and human plasma samples by laser diode thermal desorption/atmospheric pressure chemical ionization tandem mass spectrometry
- (2010) John G. Swales et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Diet-induced Obesity in Two C57BL/6 Substrains With Intact or Mutant Nicotinamide Nucleotide Transhydrogenase (Nnt) Gene
- (2010) Anthony Nicholson et al. Obesity
- Recent Advances in Antidiabetic Drug Therapies Targeting the Enteroinsular Axis
- (2009) P. Flatt et al. CURRENT DRUG METABOLISM
- Insulin Therapy for Type 2 Diabetes
- (2009) S. G. Swinnen et al. DIABETES CARE
- Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia
- (2009) Kara K. Osbak et al. HUMAN MUTATION
- Assessing the potential of glucokinase activators in diabetes therapy
- (2009) Franz M. Matschinsky NATURE REVIEWS DRUG DISCOVERY
- Impact of Small-Molecule Glucokinase Activator on Glucose Metabolism and β-Cell Mass
- (2008) Akinobu Nakamura et al. ENDOCRINOLOGY
- Glucokinase activators in diabetes management
- (2008) Matthew Coghlan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of chronic rosiglitazone, metformin and glyburide treatment on β-cell mass, function and insulin sensitivity in mZDF rats
- (2007) L. L. Atkinson et al. DIABETES OBESITY & METABOLISM
- Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice
- (2007) T. Gorman et al. DIABETES OBESITY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started